UK Clinical Research Vision To Drive Novel Trial Design
A pilot conducted by the UK medicines agency to improve patient involvement in research will support newly announced plans to improve clinical research.
You may also be interested in...
Early discussions between companies and multiple regulators could drive greater alignment among jurisdictions.
More pollical support from the National Health Service and health ministers is needed to ensure the UK’s future as a desirable launch market.
The cancer drug is also to undergo an accelerated assessment by the European Medicines Agency.